Clinical Trials Insight: 700013205
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2007
At a glance
- Drugs XTL 2125 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Sponsors XTL Biopharmaceuticals
- 14 Jun 2007 Status change
- 06 Jun 2007 Results have been reported.
- 08 Jun 2006 New trial record.